Impact of atrial fibrillation and oral anticoagulation on hospital costs and length of st…
Entries Tagged as 'Am J Health Syst Pharm'
Impact of atrial fibrillation and oral anticoagulation on hospital costs and length of stay.
May 23rd, 2012 · Start a Discussion
Tags: Am J Health Syst Pharm
Fidaxomicin: A novel macrocyclic antibiotic for the treatment of Clostridium difficile infection.
May 23rd, 2012 · Start a Discussion
Fidaxomicin: A novel macrocyclic antibiotic for the treatment of Clostridium difficile in…
Tags: Am J Health Syst Pharm
Performance of a vancomycin dosage regimen developed for obese patients.
May 23rd, 2012 · Start a Discussion
Performance of a vancomycin dosage regimen developed for obese patients.
Am J Hea…
Tags: Am J Health Syst Pharm
High-dose argatroban for treatment of heparin-induced thrombocytopenia with thrombosis: A case report and review of laboratory considerations.
March 3rd, 2012 · Start a Discussion
High-dose argatroban for treatment of heparin-induced thrombocytopenia with thrombosis: A…
Tags: Am J Health Syst Pharm
Preventing venous thromboembolism in hospitalized patients with cancer: Improving compliance with clinical practice guidelines.
March 3rd, 2012 · Start a Discussion
Preventing venous thromboembolism in hospitalized patients with cancer: Improving complia…
Tags: Am J Health Syst Pharm
Implementation of targeted interventions to decrease antiretroviral-related errors in hospitalized patients.
February 22nd, 2012 · Start a Discussion
Implementation of targeted interventions to decrease antiretroviral-related errors in hos…
Tags: Am J Health Syst Pharm
Initiative to improve thromboprophylactic enoxaparin exposure in hospitalized patients with renal impairment.
February 22nd, 2012 · Start a Discussion
Initiative to improve thromboprophylactic enoxaparin exposure in hospitalized patients wi…
Tags: Am J Health Syst Pharm
Determining vancomycin clearance in an overweight and obese population.
February 14th, 2012 · Start a Discussion
Determining vancomycin clearance in an overweight and obese population.
Am J Heal…
Tags: Am J Health Syst Pharm
Comparison of rates of reported adverse events associated with i.v. iron products in the United States.
February 4th, 2012 · Start a Discussion
Comparison of rates of reported adverse events associated with i.v. iron products in the …
Tags: Am J Health Syst Pharm
Development and implementation of a comprehensive heparin-induced thrombocytopenia recognition and management protocol.
January 21st, 2012 · Start a Discussion
Development and implementation of a comprehensive heparin-induced thrombocytopenia recogn…
Tags: Am J Health Syst Pharm
Aztreonam lysine for inhalation: New formulation of an old antibiotic.
January 5th, 2012 · Start a Discussion
Aztreonam lysine for inhalation: New formulation of an old antibiotic.
Am J Healt…
Tags: Am J Health Syst Pharm
Inpatient warfarin: Experience with a pharmacist-led anticoagulation management service in a tertiary care medical center.
December 20th, 2011 · Start a Discussion
Inpatient warfarin: Experience with a pharmacist-led anticoagulation management service i…
Tags: Am J Health Syst Pharm
New treatment options for acute edema attacks caused by hereditary angioedema.
November 8th, 2011 · Start a Discussion
New treatment options for acute edema attacks caused by hereditary angioedema.
Am…
Tags: Am J Health Syst Pharm
Improving adherence to best-practice guidelines for venous thromboembolism risk assessment and prevention.
November 8th, 2011 · Start a Discussion
Improving adherence to best-practice guidelines for venous thromboembolism risk assessmen…
Tags: Am J Health Syst Pharm
Implementation of an inpatient anticoagulation teaching service: Expanding the role of pharmacy students and residents in patient education.
November 1st, 2011 · Start a Discussion
Implementation of an inpatient anticoagulation teaching service: Expanding the role of ph…
Tags: Am J Health Syst Pharm
